Many state-funded addiction treatment services have undergone gradual cuts during the last 15 years. With the rising opioid addiction crisis in America, better access to opioid treatment is definitely needed.
There are a number of private clinics and outpatient treatment centers opening their doors in most every state. These private clinics are meeting a need for services that are often absent in more remote areas of the country.
Some new opioid treatment providers are smaller, independent methadone clinics while others are part of a larger network such as those owned by Acadia Healthcare, Behavioral Health Group (BHG), or Colonial Management Group.
They all have one thing in common, and it is that they provide their patients with medication-assisted treatment (MAT). MAT is scientifically proven to be more effective than other forms of abstinence-based treatment.
Medication assistance typically utilizes methadone or buprenorphine-based products to alleviate a patient’s chronic opioid withdrawal. Without medication-assistance, patients often face either a detox admission or they struggle on in a daily effort to secure opiates so as to prevent the return of withdrawal sickness.
People ready for opioid treatment may find that their local methadone clinic is full, or that their nearest clinic is just too far away to access on a daily basis. For some patients, suboxone/buprenorphine may be the best solution since a prescription can be obtained for several weeks of medication before a return visit is required.
Access to treatment is currently on the radar of national healthcare officials and government legislators, many of whom have received numerous letters and calls from families requesting more funding for treatment, and better access. Media coverage has also been much improved during the past 3 years in part due to the widespread opioid crisis and its broad impact.
Supporting local opioid addiction treatment services is important for every community. It ultimately saves lives, reduces crime, and promotes recovery so that addicted patients can work and function.
It was announced in June that North Dakota would be receiving its first methadone clinic. North Dakota and Wyoming are the only two states in the U.S. that have yet to provide a methadone treatment program for opioid addiction.
The region has suffered in recent years with an increase in the use of heroin and fentanyl, and with associated opioid overdoses. Kurt Snyder is the Executive Director of the new clinic, Heartview Foundation. Mr. Snyder echoed the research-based evidence showing that medication-assisted treatment for opioid addiction provides superior results to abstinence-only treatment interventions.
In the article linked above from The Jamestown Sun, a local police detective indicated that the addiction problem had recently worsened in North Dakota as a result of the price of drugs dropping.
The Heartview Foundation clinic will also offer buprenorphine and naloxone in addition to methadone thus providing a more complete range of medication assisted therapies. Therapeutic counseling and mental health treatment will be a component of the Heartview program as well as drug testing.
Of particular benefit too is the recent initiative in North Dakota that will allow pharmacists the ability to prescribe naloxone so that opioid overdoses can hopefully be greatly reduced. The ready accessibility of naloxone is receiving a nationwide push as communities struggle to address overdose concerns.
Methadone.US welcomes a new addition to the featured clinics here on the site with the listing of BrookStone Medical Center in St. George, Utah.
Posted in Addiction Treatment, Buprenorphine, Drug Rehab Programs, Drug Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Suboxone, Suboxone Doctors
Tagged Kurt Snyder, medication assisted treatment, methadone clinic north dakota, north dakota
The growing problem around opioid addiction continues to receive coverage in the media, and it has become a topic of discussion on the campaign trail because candidates are being approached throughout the country by concerned families and citizens.
Marcia Taylor, President of Partnership For Drug Free Kids, provided testimony in January to a Senate Judiciary Committee on the need to increase funding for drug prevention and drug treatment. Proposed for consideration is the CARA Senate Bill which stands for Comprehensive Addiction and Recovery Act. CARA would allocate funding for drug treatment and prevention resources with a goal of getting more addicted individuals into treatment, and better educating both parents and teens on the dangers of recreational opioid use.
CARA would also address the need to distribute naloxone across the U.S. to aid in the fight to reduce deaths from opioid overdose. Local law enforcement would be trained on the administration of naloxone. Prescription drug monitoring programs would also receive increased support under CARA.
Methadone and Suboxone have become familiar interventions for anyone knowledgeable on opioid addiction issues. Most state-funded opioid treatment programs in the United States are currently full and have waiting lists of addicted people who are eager to participate in medication-assisted treatment.
In America, there has been a notable expansion in recent years of treatment programs who utilize methadone or suboxone to help patients. While many of these programs are private self-pay, Medicaid presently pays for methadone-based treatment approaches in a number of U.S. states. The number of private pay programs currently outnumber state-funded and Medicaid-funded programs by a substantial margin.
A study by the government agency SAMHSA indicated there were approximately 254,000 patients receiving methadone for opioid addiction in 2006. In 2015, it is most likely that number is much higher given the prevalence of opioid addiction and the continued expansion of outpatient opioid treatment services in the United States. Today, there are considerably more methadone clinics and suboxone-approved physicians than there were a decade ago.
Making a new start with medication-assisted treatment is what hundreds of people across the country are deciding to do for themselves every week. Addiction is a progressive illness – one in which a person’s ability to choose is severely compromised. Medication-assisted treatment using either methadone or buprenorphine (suboxone) provides an important open door to a more responsible, quality life.
A majority of individuals suffering with opioid addiction (particularly when the illness spans years) have experienced dramatic brain changes which deepened their physiological dependency on opiates. This physical dependency is not easily removed. It is severe and persistent thus leading the person to do whatever is necessary to avoid being sick from opioid withdrawal.
Most long-term addicted individuals will tell you they rarely, if ever, get high from the illicit substances they use. They are simply trying to avoid being sick from debilitating opioid withdrawal symptoms. When a patient chooses to receive methadone or buprenorphine under the supervision of a doctor, they are making a decision to face their illness and to do something constructive about it.
As a family or friend, it is very helpful to gain an understanding of addiction and how medication-assisted treatment can be life changing for a person stuck in the cycle of opiate addiction.
Making a new start can be a bit frightening. Will methadone work for me? Will my loved ones condemn me? What about my job, or my legal situation? It becomes easy to put off making a decision when so many questions come into play.
It is important to remember that the road to recovery begins with just one step forward. That step will lead to another and another. This new start is always available. The message is one of hope and opportunity. Opiate addiction is a treatable illness. Medication-assistance can make a real difference.
Posted in Addiction Treatment, Drug Treatment, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Success, Methadone Treatment, Opiate Treatment, Recovery, Suboxone, Suboxone Doctors, Suboxone Physicians
Tagged MAT, medication-assistance, medication-assisted treatment
Acadia is a large U.S. based company who provide a broad range of behavioral healthcare services that target mental health and substance abuse problems in children, teenagers, and adults.
Their inpatient facilities provide approximately 9200 beds in 37 states including the United States, United Kingdom, and Puerto Rico. The company’s outpatient addiction services specialize in opioid addiction and medication-assisted treatment for those suffering with heroin and other opioid dependencies. Each Acadia clinic utilizes methadone and suboxone in their overall treatment.
Acadia recently acquired CRC Health Group and in so doing raised their total number of opioid treatment programs to about 90 – currently making them the single largest provider in the United States.
Acadia just added 10 more clinics to Methadone.US and site visitors can find more information about Acadia’s Opioid Treatment Programs by visiting these recently added cities on the Methadone.US website:
- Clarksburg, WV
- Galax, VA
- LaVale, MD
- Bothell, WA
- Indianapolis, IN
- Fayetteville, NC
- Roanoke, VA
- Charleston, WV
- Santa Ana, CA
- Chattanooga, TN
- San Diego, CA
- Riverside, CA
- Portland, OR
- Louisville, KY
- Baltimore, MD
Posted in Addiction Recovery, California Drug Treatment, Drug Rehab Programs, Heroin, Medication Assisted Treatment, Methadone, Methadone Benefits, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Treatment, Recovery, Suboxone, Suboxone Clinics, Suboxone Doctors
Tagged Acadia, behavioral healthcare, medication-assisted treatment, opioid treatment